Overview

This trial is active, not recruiting.

Condition lung cancer
Sponsor Tata Memorial Hospital
Start date July 2010
End date October 2013
Trial size 200 participants
Trial identifier NCT01133067, PROJECT NO 754

Summary

Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Measure
Concurrence between the telephonic interview and the physician assessment
time frame: 2 years

Secondary Outcomes

Measure
Validation of the telephonic questionnaire grand score with the disease free and overall survival
time frame: 2 years
Cost analysis
time frame: 2 years

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: 1. All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination) 2. Patients should have completed radical /adjuvant treatment, if any 3. Patients of both SCLC and NSCLC 4. Patients with at least two telephone numbers (landline/mobile/both) 5. Patients willing to participate Exclusion Criteria: 1. All patients for palliative intention 2. Patients with less than two contact telephone numbers -

Additional Information

Official title A Prospective Study of Telephonic Contact and Subsequent Physical Follow up of Radically Treated Lung Cancer Patients
Principal investigator JP AGARWAL, MD
Description Patients of cancer, after their primary treatment are subsequently called for follow up visits to assess the disease status. This has two important implications from the point of view of resource management. One, patients often have to travel long distances to report to the hospital and have to take care of other logistics such as their accommodation, local travel and food. Further often the patient travels with 1-2 attendants which adds to the logistic burden. Also, these patients of follow up also contribute to the load on existing hospital services. Many authors have speculated that follow-up visits generate anxiety about possible disease recurrence. On the other hand, many others have suggested that although there may be a transient increase in anxiety, patients are ultimately reassured by this practice. Hence, there is no firm evidence for the practice and the need for follow up in oncology care.
Trial information was received from ClinicalTrials.gov and was last updated in July 2014.
Information provided to ClinicalTrials.gov by Tata Memorial Hospital.